Cash Flow Statement

The cash flow statement provides information about a company cash receipts and cash payments during an accounting period, showing how these cash flows link the ending cash balance to the beginning balance shown on the company balance sheet.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Medtronic PLC, consolidated cash flow statement

US$ in millions

12 months ended:	Apr 26, 2024	Apr 28, 2023	Apr 29, 2022	Apr 30, 2021	Apr 24, 2020	Apr 26, 2019
Net income	3,705)	3,784)	5,062)	3,630)	4,806)	4,650)
Depreciation and amortization	2,647)	2,697)	2,707)	2,702)	2,663)	2,659)
Provision for credit losses	90)	73)	58)	128)	99)	78)
Deferred income taxes	(508)	(226)	(604)	(422)	(1,315)	(304)
Stock-based compensation	393)	355)	359)	344)	297)	290)
Loss on debt extinguishment	—)	53)	—)	308)	406)	457)
Asset impairments and related inventory write-downs	371)	—)	515)	—)	—)	—)
Other, net	573)	270)	138)	251)	217)	257)
Accounts receivable, net	(391)	(576)	(477)	(761)	1,291)	(581)
Inventories, net	(139)	(939)	(560)	78)	(577)	(274)
Accounts payable and accrued liabilities	391)	696)	213)	531)	(44)	399)
Other operating assets and liabilities	(345)	(148)	(65)	(549)	(609)	(624)
Change in operating assets and liabilities, net of acquisitions and divestitures	(484)	(967)	(889)	(701)	61)	(1,080)
Adjustments to reconcile net income to net cash provided by operating activities	3,082)	2,255)	2,284)	2,610)	2,428)	2,357)
Net cash provided by operating activities	6,787)	6,039)	7,346)	6,240)	7,234)	7,007)
Acquisitions, net of cash acquired	(211)	(1,867)	(91)	(994)	(488)	(1,827)
Additions to property, plant, and equipment	(1,587)	(1,459)	(1,368)	(1,355)	(1,213)	(1,134)
Purchases of investments	(7,748)	(7,514)	(9,882)	(11,808)	(11,039)	(2,532)
Sales and maturities of investments	7,441)	7,343)	9,692)	11,345)	9,574)	4,683)
Other investing activities, net	(261)	4)	(10)	(54)	(37)	36)
Net cash used in investing activities	(2,366)	(3,493)	(1,659)	(2,866)	(3,203)	(774)
Change in current debt obligations, net	1,073)	—)	—)	(311)	(17)	(713)
Proceeds from short-term borrowings, maturities greater than 90 days	—)	2,284)	—)	2,789)	—)	—)
Repayments from short-term borrowings, maturities greater than 90 days	—)	(2,279)	—)	(2,853)	—)	—)
Issuance of long-term debt	—)	5,409)	—)	7,172)	5,568)	7,794)
Payments on long-term debt	—)	(6,012)	(1)	(7,367)	(6,110)	(7,948)
Dividends to shareholders	(3,666)	(3,616)	(3,383)	(3,120)	(2,894)	(2,693)
Issuance of ordinary shares	284)	308)	429)	474)	662)	992)
Repurchase of ordinary shares	(2,138)	(645)	(2,544)	(652)	(1,326)	(2,877)
Other financing activities	(3)	(409)	163)	(268)	(81)	14)
Net cash used in financing activities	(4,450)	(4,960)	(5,336)	(4,136)	(4,198)	(5,431)
Effect of exchange rate changes on cash and cash equivalents	(230)	243)	(230)	215)	(86)	(78)
Net change in cash and cash equivalents	(259)	(2,171)	121)	(547)	(253)	724)
Cash and cash equivalents at beginning of period	1,543)	3,714)	3,593)	4,140)	4,393)	3,669)
Cash and cash equivalents at end of period	1,284)	1,543)	3,714)	3,593)	4,140)	4,393)

Based on: 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26).

Download chart

Cash flow statement item	Description	The company
Net cash provided by operating activities	Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.	Medtronic PLC net cash provided by operating activities decreased from 2022 to 2023 but then increased from 2023 to 2024 not reaching 2022 level.
Net cash used in investing activities	Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.	Medtronic PLC net cash used in investing activities decreased from 2022 to 2023 but then increased from 2023 to 2024 not reaching 2022 level.
Net cash used in financing activities	Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.	Medtronic PLC net cash used in financing activities increased from 2022 to 2023 and from 2023 to 2024.

Medtronic PLC (NYSE:MDT)

Cash Flow Statement